JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (4): 43-49.doi: 10.6040/j.issn.1673-3770.0.2016.224

Previous Articles     Next Articles

Predictive biomarkers for dust mite specific immunotherapy in patients with allergic rhinitis.

ZHOU Wencheng, YUAN Yuan, CHENG Lei   

  1. Department of Otorhinolaryngology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China
  • Received:2016-05-15 Online:2016-08-16 Published:2016-08-16

PDF (PC)

859

Abstract: Objective To investigate the changes of serum total IgE(tIgE)and specific IgE(sIgE)levels in patients with allergic rhinitis(AR)one year after allergen-specific immunotherapy, and so as to explore the predictive biomarkers for therapeutic effects of subcutaneous immunotherapy(SCIT)and sublingual immunotherapy(SLIT). Methods Patients with moderate-to-severe persistent AR who completed one year of dust mite specific immunotherapy were enrolled in this study. The effectiveness of immunotherapy was evaluated by patient-reported outcomes. The changes of serum tIgE, Dp-sIgE and Df-sIgE levels were compared before and after immunotherapy, and these antibody levels were stratified analyzed based on the responders and nonresponders of treatment. The baseline serum IgE levels before immunotherapy were tested for correlation with clinical response to the treatment, and the best predictive biomarkers and cut-off value for discriminating between responders and nonresponders were estimated on the basis of the receiver operator characteristic(ROC)curve. Results The effective rate of the SCIT group(n=50)and the SLIT group(n=58)was 64% and 65.5% after one year immunotherapy, respectively. And there was no statistical significant difference between the two groups(P>0.05). Also, no significant differences in the levels of tIgE, Dp-sIgE and Df-sIgE were observed in both groups before and after immunotherapy(P>0.05). However, a significant decreased serum Dp-sIgE level was found in the responders of treatment in the SCIT group. The using of baseline serum Dp-sIgE/tIgE ratio > 11.95% as a biomarker of effective SCIT yielded a sensitivity value of 71.9% and a specificity of 83.3%. As for SLIT, the serum Df-sIgE levels > 27.95 IU/ml(grade 4)yielded a sensitivity value of 52.6% and a specificity of 85.0%. Conclusion Serum sIgE level before immunotherapy could be a useful biomarker for predicting response to the treatment. Generally, patients with higher levels of sIgE or sIgE/tIgE ratios may be more likely to achieve therapeutic effect.

Key words: Allergic rhinitis, Immunotherapy, Biomarkers, Receiver operating characteristic curve, Immunoglobulin E

CLC Number: 

  • R765.21
[1] Zhang Y, Zhang L. Prevalence of allergic rhinitis in China[J]. Allergy Asthma Immunol Res, 2014, 6(2):105-113.
[2] 程雷. 变应性鼻炎的特异性免疫治疗[J]. 山东大学耳鼻喉眼学报, 2011, 25(5):33-35.
[3] 程雷. 舌下免疫治疗在中国的临床应用及若干问题探讨[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(8):617-618.
[4] 中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎特异性免疫治疗专家共识[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(12):976-980.
[5] Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy[J]. J Allergy Clin Immunol, 2015, 136(3):556-568.
[6] Canonica G W, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update[J]. World Allergy Organ J, 2014, 7(1):6.
[7] Walker S M, Durham S R, Till S J, et al. Immunotherapy for allergic rhinitis[J]. Clin Exp Allergy, 2011, 41(9):1177-1200.
[8] 中华医学会耳鼻咽喉头颈外科学分会鼻科学组,中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组. 变应性鼻炎诊断和治疗指南(2015年,天津)[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(1):6-24.
[9] 中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2009年,武夷山)[J]. 中华耳鼻咽喉头颈外科杂志, 2009, 44(12):977-978.
[10] Bergmann K C, Demoly P, Worm M, et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis[J]. J Allergy Clin Immunol, 2014, 133(6):1608-1614.
[11] Bousquet J, Khaltaev N, Cruz A A, et al. Allergic Rhinitis and its Impact on Asthma(ARIA)2008 update(in collaboration with the World Health Organization, GA(2)LEN and AllerGen)[J]. Allergy, 2008, 63 Suppl 86:8-160.
[12] Brozek J L, Bousquet J, Baena-Cagnani C E, et al. Allergic Rhinitis and its Impact on Asthma(ARIA)guidelines: 2010 revision[J]. J Allergy Clin Immunol, 2010, 126(3):466-476.
[13] Ciprandi G, Tosca M A, Silvestri M. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy[J]. Expert Rev Clin Immunol, 2014, 10(3):321-324.
[14] de Bot C M, Moed H, Berger M Y, et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care[J]. Pediatr Allergy Immunol, 2012, 23(2):150-158.
[15] Zuberbier T, Bachert C, Bousquet P J,et al. GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy, 2010, 65(12):1525-1530.
[16] Chelladurai Y, Suarez-Cuervo C, Erekosima N, et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review[J]. J Allergy Clin Immunol Pract, 2013, 1(4):361-369.
[17] Okubo K, Kurono Y, Fujieda S, et al. Japanese Guideline for Allergic Rhinitis 2014[J]. Allergol Int, 2014, 63(3):357-375.
[18] Seidman M D, Gurgel R K, Lin S Y, et al. Clinical practice guideline: Allergic rhinitis[J]. Otolaryngol Head Neck Surg, 2015, 152(Suppl 1):S1-S43.
[19] Yukselen A, Kendirli S G, Yilmaz M, et al. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study[J]. Int Arch Allergy Immunol, 2012, 157(3):288-298.
[20] Radulovic S, Wilson D, Calderon M, et al. Systematic reviews of sublingual immunotherapy(SLIT)[J]. Allergy, 2011, 66(6):740-752.
[21] Akdis C A, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens[J]. World Allergy Organ J, 2015, 8(1):17.
[22] Zhao D, Lai X, Tian M, et al. The functional IgE-blocking factor induced by allergen-specific immunotherapy correlates with IgG4 antibodies and a decrease of symptoms in house dust mite-allergic Children[J]. Int Arch Allergy Immunol, 2016, 169(2):113-120.
[23] Shamji M H, Ljorring C, Francis J N, et al. Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy[J]. Allergy, 2012, 67(2):217-226.
[24] Calderon M, Cardona V, Demoly P. One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions[J]. Allergy, 2012, 67(4):462-476.
[25] Tosca M, Silvestri M, Accogli A, et al. Serum-specific IgE and allergen immunotherapy in allergic children[J]. Immunotherapy, 2014, 6(1):29-33.
[26] Ciprandi G, Silvestri M. Serum specific IgE: a biomarker of response to allergen immunotherapy[J]. J Investig Allergol Clin Immunol, 2014, 24(1):35-39.
[27] Di Lorenzo G, Mansueto P, Pacor M L, et al. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy[J]. J Allergy Clin Immunol, 2009, 123(5):1103-1110.
[28] 刘靖,张晓波,冯海燕,等. 影响儿童哮喘尘螨特异性免疫疗效的因素分析[J]. 中国当代儿科杂志, 2013, 15(10):854-859. LIU Jing, ZHANG Xiaobo, FENG Haiyan, et al. Impact factors for efficacy of specific immunotherapy in children with dust mite allergic asthma[J]. Chin J Contem Pedia, 2013, 15(10):854-859.
[1] WANG Tan, WU Ke, LI Lianqing, GONG Lili. Factors associated with systemic adverse reactions after subcutaneous immunotherapy injections and treatment options [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 71-74.
[2] LU Hangui, LIN Xinsheng, YAO Danmian, WEI Yongxin, LI Chuangwei. Expression of IL-35 in allergic rhinitis and its effect on the immunoregulation of T cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 66-70.
[3] PU Hongbo, DU Xiaodong. Allergen test results in 2 000 patients with allergic rhinitis in Wuxi District [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 105-107.
[4] CHEN Ming, YU Xuefei. Opinions on the treatment of chronic rhinosinusitis with allergic rhinitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 18-22.
[5] QIN Gang, LIANG Zhuoping. Status of immunotherapy in allergic fungal rhinosinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 23-26.
[6] WU Xiangping. Influence of patient management on the clinical effect of sublingual dermatophagoides farinae drops in patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 68-72.
[7] LI Song, WANG Zonggui, YANG Jingpu, ZHANG Zhuping. Progress of transnasal endoscopic vidian neurectomy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 72-76.
[8] ZHI Lili, SONG Daoliang. Expressions of eosinophils and IL5 in antrochoanal polyps and nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 43-46.
[9] WAN Wenjin, WANG Wen, CHENG Lei. A meta-analysis of subcutaneous immunotherapy and sublingual immunotherapy in the treatment of dust mite-allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 103-108.
[10] ZHU Xinhua. Clinical applicationof rush immunotherapy for allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 13-17.
[11] LIU Huaitao, MA Ruixia, CHENG Lei. Surgical treatment of refractory allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 18-21.
[12] GUAN Kai, LI Lisha. Nasal irrigation and its role in the treatment of allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 22-27.
[13] SHI Li, ZHAO Li, ZHANG Hongping. Long-term anti-inflammatory treatment of allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 9-12.
[14] LIU Jing. Treatment of allergic rhinitis using syndrome differentiation based on the concept of “holism” in TCM. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 28-30.
[15] CHENG Lei, QIAN Junjun, TIAN Huiqin. Research progresses on allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 1-3.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd